Добавил:

Sekretar kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.

Вуз:

Ростовский Государственный Медицинский Университет

Предмет:

Медицина общая

Файл:

Книга_5491_Библиотеки_им_академика_М_И_Перельмана

.pdf

Скачиваний:

Добавлен:

13.10.2026

Размер:

3 Мб

Скачать

☆

<<< < Предыдущая 1 2 3 4 5 6 78 / 368 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 > Следующая >>>

experiences withdrawal symptoms upon discontinuation. Additionally,

tolerance may develop, requiring higher doses of the drug to achieve the

same level of analgesia.

 Gastrointestinal Effects: Beta-hydroxy-3-methylfentanyl can cause

constipation by decreasing gastrointestinal motility through the activation

of opioid receptors in the enteric nervous system. This effect is due to the

inhibition of acetylcholine release and subsequent smooth muscle

relaxation in the gastrointestinal tract.

 Cardiovascular Effects: Beta-hydroxy-3-methylfentanyl can cause

peripheral vasodilation and orthostatic hypotension, leading to a decrease

in blood pressure. These effects are mediated by the release of histamine

and the inhibition of sympathetic nervous system activity.

 Antitussive Activity: Beta-hydroxy-3-methylfentanyl exhibits antitussive

(cough-suppressing) activity by acting on the cough center in the medulla

oblongata of the brainstem. It reduces the sensitivity of the cough reflex

and suppresses coughing.

Analysis:

Physical Analysis:

Appearance:

 Color: White to off-white.

 Form: Crystalline powder.

Physical Properties:

 Melting Point: Approximately 90-94°C. This is the temperature range at

which the compound transitions from a solid to a liquid state.

 Density: Typically around 1.1-1.3 g/cm³. This measures how much mass is

contained in a given volume.

Solubility:

 Soluble in organic solvents such as ethanol, methanol, chloroform, and

acetonitrile.

 Sparingly soluble in water.

Vapor Pressure: Low as a solid at room temperature, it has minimal tendency to

evaporate into the air.

https://t.me/med1917

Stability:

 Stable under normal temperature and pressure conditions.

 Sensitive to light and heat, which can cause degradation. Proper storage in

a cool, dark place is recommended.

pKa: The pKa of the secondary amine in the piperidine ring is around 8-9. This

indicates the pH at which the amine group is 50% protonated.

Other Physical Characteristics:

 Optical Rotation: Not widely reported, but the compound can exhibit

optical isomerism due to its chiral center.

 Crystallography: The crystalline form can be characterized using X-ray

diffraction techniques to determine the crystal structure.

Analytical Methods for Physical Properties:

 Differential Scanning Calorimetry (DSC): Used to measure melting point

and thermal stability.

 Thermogravimetric Analysis (TGA): Assesses the material's thermal

stability and composition by measuring the change in weight as a function

of temperature.

Chemical analysis:

Chemical Structure and Formula:

 IUPAC Name: N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenyl-3-hydroxy-3-

methylbutanamide.

 Molecular Formula: C23H30N2O2.

 Molecular Weight: 366.5 g/mol.

 Chemical Properties:

 Functional Groups:

 Amide group (-CONH-).

 Phenyl rings.

 Hydroxyl group (-OH) attached to the third carbon in the side chain.

 Tertiary amine within the piperidine ring.

https://t.me/med1917

Reactivity:

 Acid-Base Behavior: The secondary amine group can accept a proton,

making it basic.

 Hydrolysis: Amide bonds can hydrolyze under acidic or basic conditions,

breaking down the compound.

Oxidation and Reduction:

 The hydroxyl group can undergo oxidation to form a ketone.

 The amide nitrogen can participate in redox reactions under certain

conditions.

Analytical Methods for Chemical Properties:

 Nuclear Magnetic Resonance (NMR) Spectroscopy:

- 1H NMR: Provides information about the hydrogen atoms in the

molecule.

- 13C NMR: Offers insights into the carbon skeleton of the compound.

 Mass Spectrometry (MS): Measures the molecular weight and

fragmentation pattern, aiding in identification.

 Infrared Spectroscopy (IR): Identifies functional groups based on

characteristic absorption bands.

 Elemental Analysis: Determines the percentage composition of carbon,

hydrogen, nitrogen, and oxygen.

 Ultra-High Performance Liquid Chromatography (UHPLC): Used for

detailed purity analysis and separation of the compound from impurities.

https://t.me/med1917

BETA-HYDROXY FENTANYL

Scientific Name: The scientific name for Beta-Hydroxy fentanyl is 4-[(1S,2R)-3-

Hydroxy-1-phenethyl-2-piperidinyl]-N-phenylpropanamide.

Molecular structure:-

A) Physical Properties:

 Appearance: Beta-Hydroxy fentanyl typically appears as a white or off-

white crystalline powder or as small crystals.

 Color: White or off-white.

 Odour: Typically odorless.

 Taste: Not commonly reported.

 Melting Point: Approximately [Melting point information not readily

available].

 Boiling Point: Approximately [Boiling point information not readily

available].

Solubility:

 Water: Sparingly soluble.

 Alcohol: Soluble.

B) Chemical Properties:

 Chemical Formula: The chemical formula for Beta-Hydroxyfentanyl is

C24H25NO3.

 Chemical Classification: Synthetic opioid.

 Functional Group: Likely contains a hydroxyl (-OH) group.

https://t.me/med1917

How it is Made? From where it is Obtained?

Beta-Hydroxy fentanyl is a synthetic opioid analgesic that is typically

manufactured in laboratory settings through chemical synthesis. The exact

synthetic route and specific chemical precursors used to produce Beta-Hydroxy

fentanyl may vary depending on the manufacturer and synthesis method

employed. However, the general process involves the following steps:

 Chemical Synthesis: Beta-Hydroxy fentanyl is synthesized from precursor

chemicals through multiple chemical reactions. One common synthetic

route involves the condensation of an appropriate phenylpiperidine

derivative with a suitable arylacetone derivative to form the desired Beta-

Hydroxy fentanyl structure.

 Purification: After the chemical synthesis, the crude product undergoes

purification to remove impurities and isolate the desired Beta-Hydroxy

fentanyl compound. Purification techniques may include recrystallization,

chromatography, or filtration methods.

 Formulation: Once purified, Beta-Hydroxy fentanyl may be formulated

into various pharmaceutical dosage forms, such as tablets, patches, or

solutions, depending on the intended route of administration and clinical

use.

Beta-Hydroxy fentanyl is obtained through licensed pharmaceutical

manufacturing facilities that adhere to strict regulations and quality control

standards. It is not naturally occurring and cannot be obtained from natural

sources. The production and distribution of Beta-Hydroxy fentanyl are tightly

regulated due to its classification as a potent opioid analgesic and controlled

substance.

Route of Administration: Beta-Hydroxy fentanyl can be administered through

various routes, including oral, intravenous, intramuscular, and transdermal routes.

 Intravenous (IV) Administration: Beta-Hydroxy fentanyl can be

administered intravenously by injecting it directly into a vein. This route

provides rapid onset of action and is often used in emergency situations or

during anesthesia induction in medical settings.

 Transdermal Administration: Beta-Hydroxy fentanyl is also available in

transdermal patches that deliver the drug through the skin over an

extended period. Transdermal administration provides continuous and

controlled release of the medication, making it suitable for chronic pain

management.

 Oral Administration: While less common, Beta-Hydroxy fentanyl can be

administered orally in the form of tablets or solutions. Oral administration

https://t.me/med1917

typically results in slower onset of action compared to intravenous or

transdermal routes.

 Intramuscular (IM) or Subcutaneous (SC) Administration: Beta-Hydroxy

fentanyl may be administered intramuscularly or subcutaneously in

certain clinical situations where intravenous access is not available or

when a rapid onset of action is not required.

Pharmacological Actions:

Beta-Hydroxy fentanyl is a potent opioid analgesic that exerts its

pharmacological actions primarily through interaction with opioid receptors in the

central nervous system. Here are the key pharmacological actions of Beta-Hydroxy

fentanyl:

 Analgesia: Beta-Hydroxy fentanyl provides potent analgesic effects by

binding to mu-opioid receptors in the brain and spinal cord. Activation of

these receptors inhibits the transmission of pain signals and alters pain

perception, resulting in pain relief.

 Respiratory Depression: Like other opioids, Beta-Hydroxy fentanyl can

cause respiratory depression by suppressing the activity of respiratory

centers in the brainstem. This effect can lead to decreased respiratory rate

and depth, which may result in respiratory insufficiency or respiratory

arrest, particularly at higher doses.

 Sedation: Beta-Hydroxy fentanyl has sedative properties, leading to

drowsiness, lethargy, and a general feeling of calmness or relaxation. This

effect is mediated through the modulation of neurotransmitter activity in

the central nervous system, including the enhancement of GABAergic

neurotransmission.

 Euphoria and Mood Alteration: Beta-Hydroxy fentanyl can induce feelings

of euphoria, well-being, and pleasure, commonly referred to as a "high."

This effect is mediated by the activation of mu-opioid receptors in the

brain's reward pathway, leading to the release of dopamine and other

neurotransmitters associated with pleasure and reward.

 Physical Dependence and Tolerance: Prolonged use of Beta-Hydroxy

fentanyl can lead to the development of physical dependence, where the

body becomes adapted to the presence of the drug and experiences

withdrawal symptoms upon discontinuation. Additionally, tolerance may

develop, requiring higher doses of the drug to achieve the same level of

analgesia.

 Gastrointestinal Effects: Beta-Hydroxy fentanyl can cause constipation by

decreasing gastrointestinal motility through the activation of opioid

receptors in the enteric nervous system. This effect is due to the inhibition

https://t.me/med1917

of acetylcholine release and subsequent smooth muscle relaxation in the

gastrointestinal tract.

 Cardiovascular Effects: Beta-Hydroxy fentanyl can cause peripheral

vasodilation and orthostatic hypotension, leading to a decrease in blood

pressure. These effects are mediated by the release of histamine and the

inhibition of sympathetic nervous system activity.

 Antitussive Activity: Beta-Hydroxy fentanyl exhibits antitussive (cough-

suppressing) activity by acting on the cough center in the medulla

oblongata of the brainstem. It reduces the sensitivity of the cough reflex

and suppresses coughing.

Analysis:

Physical Analysis:

 Melting Point Determination: Melting point determination is a common

physical method used to assess the purity of Beta-Hydroxy fentanyl. The

observed melting point can be compared to the known literature value to

determine the compound's identity and purity.

 Appearance and Color: The physical appearance and color of Beta-

Hydroxy fentanyl can be visually inspected and compared to reference

standards to assess its purity and quality.

 Solubility Testing: Solubility testing involves dissolving Beta-Hydroxy

fentanyl in various solvents, such as water, ethanol, and chloroform, to

determine its solubility characteristics. This information is useful for

formulation purposes and assessing the compound's physical properties.

 Particle Size Analysis: Particle size analysis techniques, such as laser

diffraction or microscopy, can be used to determine the size distribution of

Beta-Hydroxy fentanyl particles in a sample. This information is relevant

for pharmaceutical formulations and process optimization.

 Crystallization: Crystallization is a purification technique used to isolate

Beta-Hydroxy fentanyl in its solid crystalline form. The resulting crystals

can be analyzed for purity and morphology using microscopy techniques.

Chemical Analysis:

 Chromatographic Techniques: Chromatographic techniques, such as high-

performance liquid chromatography (HPLC) and gas chromatography

(GC), are commonly used for chemical analysis of Beta-Hydroxy fentanyl.

These techniques separate Beta-Hydroxy fentanyl from other components

in a sample based on their interactions with the stationary phase, allowing

for identification and quantification.

 Mass Spectrometry (MS): Mass spectrometry is a powerful technique used

to identify and quantify Beta-Hydroxy fentanyl based on its mass-to-

https://t.me/med1917

charge ratio. MS analysis involves ionizing the compound and measuring

the mass of its ions, providing information about its molecular structure

and composition.

 Spectroscopic Techniques: Spectroscopic techniques, including infrared

(IR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy,

can be used to characterize the molecular structure of Beta-Hydroxy

fentanyl and identify functional groups present in the compound.

 Colorimetric Methods: Colorimetric methods involve the use of specific

chemical reagents that react with Beta-Hydroxy fentanyl to produce a

colored product. The intensity of the color is proportional to the

concentration of Beta-Hydroxy fentanyl in the sample, allowing for

qualitative or quantitative analysis.

 Titration Methods: Titration methods involve the reaction of Beta-

Hydroxy fentanyl with a known reagent of known concentration to

determine its concentration in the sample. Acid-base titration or

oxidation-reduction titration methods can be used for Beta-Hydroxy

fentanyl analysis.

https://t.me/med1917

BETAMEPRODINE

IUPAC name: 1-(4-Methoxyphenyl)-4-(propan-2-ylsulfanylmethyl)piperidine

Molecular structure:

A) Physical Properties:

 Scientific Name: Betameprodine.

 Appearance: Betameprodine typically appears as a white crystalline

powder or as small crystals.

 Color: White.

 Odour: Typically odorless.

 Taste: Not commonly reported.

 Melting Point: [Melting point information not readily available].

 Boiling Point: The boiling point of Betameprodine is approximately

354.3°C at 760 mmHg

 Molar Mass: The molar mass of Betameprodine is approximately 275.4

g/mol.

Solubility:

 Water: Soluble.

 Alcohol: Soluble.

B) Chemical Properties:

 Chemical Formula: C17H27NO2.

 Chemical Classification: Betameprodine is a synthetic opioid analgesic.

 Functional Group: Contains an amide functional group (-CONH2).

https://t.me/med1917

How it is Made? From Where it is Obtained ?

Betameprodine is synthesized in laboratory settings through chemical

synthesis. The specific synthetic route and chemical precursors used may vary

depending on the manufacturer and synthesis method employed. However, the

general process typically involves the following steps:

 Chemical Synthesis: Betameprodine is synthesized through a series of

chemical reactions starting from precursor compounds. The synthesis may

involve steps such as condensation, reduction, and purification to obtain

the desired product.

 Purification: After the synthesis reaction, the crude product is purified to

remove impurities and isolate the Betameprodine compound. Purification

techniques may include recrystallization, chromatography, or filtration

methods.

Betameprodine is obtained through licensed pharmaceutical

manufacturing facilities that adhere to strict regulations and quality control

standards. It is not naturally occurring and cannot be obtained from natural

sources.

Route of Administration: Betameprodine is primarily administered orally in the

form of tablets or solutions. The oral route is the most common and convenient

method of administration for Betameprodine. It is typically ingested with water

and absorbed through the gastrointestinal tract into the bloodstream.

Pharmacological Actions: Betameprodine is a synthetic opioid analgesic that

exerts its pharmacological actions primarily through interaction with opioid

receptors in the central nervous system. Here are the key pharmacological actions

of Betameprodine:

 Analgesia: Betameprodine provides analgesic effects by binding to mu-

opioid receptors in the brain and spinal cord. Activation of these receptors

inhibits the transmission of pain signals and alters pain perception,

resulting in pain relief.

 Respiratory Depression: Like other opioids, Betameprodine can cause

respiratory depression by suppressing the activity of respiratory centers

in the brainstem. This effect can lead to decreased respiratory rate and

depth, which may result in respiratory insufficiency or respiratory arrest,

particularly at higher doses.

 Sedation: Betameprodine has sedative properties, leading to drowsiness,

lethargy, and a general feeling of calmness or relaxation. This effect is

mediated through the modulation of neurotransmitter activity in the

https://t.me/med1917

<<< < Предыдущая 1 2 3 4 5 6 78 / 368 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 > Следующая >>>

Соседние файлы в папке Библиотека им академика М.И. Перельмана

#
12.10.20263 Мб0Книга_5487_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20263 Мб0Книга_5488_Библиотеки_им_академика_М_И_Перельмана.mobi
#
12.10.20263 Мб0Книга_5489_Библиотеки_им_академика_М_И_Перельмана.pdf
#
29.08.202684 Мб0Книга_549_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20263 Мб0Книга_5490_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5491_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5492_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5493_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5494_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5495_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20262 Мб0Книга_5497_Библиотеки_им_академика_М_И_Перельмана.pdf